Prime Medicine Inc

PRMENASDAQ · USD
3.13USD0.00 (-11.59%)
132

Prime Medicine Inc (PRME) Covered Calls

As of September 22, 2026, PRME has 15 covered call opportunities in the coming three months. Return ranges from 27.0 to 288.7% until expiration. Annualized return ranges from 28.4 to 873.9%. The nearest expiration is January 15, 2027. Maximum potential profit is $921.

Read more

Running PRME covered calls helps you generate consistent income from Prime Medicine Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Prime Medicine Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best PRME covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if PRME stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling PRME covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Prime Medicine Inc covered call is worth writing.

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

Income-focused investors, long-term PRME holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling PRME covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Prime Medicine Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile55.16% Neutral
  • Market cap (M$)568
  • 52 weeks high-54.90%
  • 52 weeks low17.23%
  • Analyst recommendationStrong Buy
    1.43
  • Target price$7.11
    127.16% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-06
  • P/E
  • Future P/E
  • EPS (ttm)-1.09
  • EPS growth next 5 years13.88%

As of September 22, 2026

2027-01-1511612.00276.180.050.40886.00277.74873.93-1.57+0.198850.35
2027-01-151167.00119.440.100.30391.00122.57385.67-3.13+0.229710.20
2027-01-151166.0088.090.100.50291.0091.22287.04-3.13+0.29810.40
2028-01-2148712.00276.180.401.40921.00288.71216.39-12.54+0.481,4601.00
2027-01-151165.0056.740.300.40211.0066.14208.13-9.40+0.355,6370.10
2028-01-2148710.00213.480.551.55736.00230.72172.92-17.24+0.546591.00
2028-01-214877.00119.440.901.85471.00147.65110.66-28.21+0.648120.95
2027-04-162075.0056.740.151.15196.0061.44108.34-4.70+0.4891.00
2027-01-151164.0025.390.050.5086.0026.9684.83-1.57+0.389290.45
2027-04-162074.0025.390.701.55151.0047.3483.47-21.94+0.641700.85

As of September 22, 2026

Sell covered calls with the data behind you

Find the best PRME covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial